ClinicalTrials.Veeva

Menu
J

JSC Inlita | Santaros KTC - Vilnius, Lithuania

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Vicadrostat
BI 690517
CDX-0159
Empagliflozin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

Rationale: Allergic rhinitis/rhinoconjunctivitis (ARC) is a global health problem, affecting 10-25% of the population. Allergen-specific immunotherap...

Active, not recruiting
House Dust Mite Rhinitis
House Dust Mite Allergy
Biological: PURETHAL Mites 50,000 AUeq/ml
Biological: Biological/Vaccine: Placebo
Locations recently updated

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Enrolling
Hypertension
Cardiovascular Diseases
Drug: Placebo matching Vicadrostat
Drug: Vicadrostat

Trial sponsors

Boehringer Ingelheim logo
Celldex Therapeutics logo
H
Lilly logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems